The global market for Sexually Transmitted Diseases (STDs) Testing Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Sexually Transmitted Diseases (STDs) Testing Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sexually Transmitted Diseases (STDs) Testing Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Sexually Transmitted Diseases (STDs) Testing Devices include Roche Diagnostics, BioMerieux, Hologic, Inc., Becton Dickinson & Company, Cepheid, Inc., Danaher Corporation, Affymetrix, Inc., Alere, Inc., Abbott Laboratories, DiaSorin, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Diseases (STDs) Testing Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Diseases (STDs) Testing Devices.
The Sexually Transmitted Diseases (STDs) Testing Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sexually Transmitted Diseases (STDs) Testing Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sexually Transmitted Diseases (STDs) Testing Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche Diagnostics
BioMerieux
Hologic, Inc.
Becton Dickinson & Company
Cepheid, Inc.
Danaher Corporation
Affymetrix, Inc.
Alere, Inc.
Abbott Laboratories
DiaSorin
Segment by Type
Thermal Cyclers
Lateral Flow Readers
Flow Cytometers
Differential Light Scattering Machines
Others
Segment by Application
Laboratory Testing
Point of Care Testing
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sexually Transmitted Diseases (STDs) Testing Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sexually Transmitted Diseases (STDs) Testing Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Overview
1.1 Product Definition
1.2 Sexually Transmitted Diseases (STDs) Testing Devices by Type
1.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Thermal Cyclers
1.2.3 Lateral Flow Readers
1.2.4 Flow Cytometers
1.2.5 Differential Light Scattering Machines
1.2.6 Others
1.3 Sexually Transmitted Diseases (STDs) Testing Devices by Application
1.3.1 Global Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Laboratory Testing
1.3.3 Point of Care Testing
1.4 Global Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue 2020-2031
1.4.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales 2020-2031
1.4.3 Global Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Competition by Manufacturers
2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sexually Transmitted Diseases (STDs) Testing Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sexually Transmitted Diseases (STDs) Testing Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sexually Transmitted Diseases (STDs) Testing Devices, Product Type & Application
2.7 Global Key Manufacturers of Sexually Transmitted Diseases (STDs) Testing Devices, Date of Enter into This Industry
2.8 Global Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Competitive Situation and Trends
2.8.1 Global Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Sexually Transmitted Diseases (STDs) Testing Devices Players 麻豆原创 Share by Revenue
2.8.3 Global Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Scenario by Region
3.1 Global Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales by Region: 2020-2031
3.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales by Region: 2020-2025
3.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales by Region: 2026-2031
3.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Region: 2020-2031
3.3.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Region: 2020-2025
3.3.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Region: 2026-2031
3.4 North America Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Facts & Figures by Country
3.4.1 North America Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2031)
3.4.3 North America Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Facts & Figures by Country
3.5.1 Europe Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2031)
3.5.3 Europe Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sexually Transmitted Diseases (STDs) Testing Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2031)
3.7.3 Latin America Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2031)
4.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025)
4.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2026-2031)
4.1.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Type (2020-2031)
4.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Type (2020-2025)
4.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Type (2026-2031)
4.2.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2031)
5.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025)
5.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2026-2031)
5.1.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Application (2020-2031)
5.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Application (2020-2025)
5.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Application (2026-2031)
5.2.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche Diagnostics
6.1.1 Roche Diagnostics Company Information
6.1.2 Roche Diagnostics Description and Business Overview
6.1.3 Roche Diagnostics Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Diagnostics Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolio
6.1.5 Roche Diagnostics Recent Developments/Updates
6.2 BioMerieux
6.2.1 BioMerieux Company Information
6.2.2 BioMerieux Description and Business Overview
6.2.3 BioMerieux Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BioMerieux Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolio
6.2.5 BioMerieux Recent Developments/Updates
6.3 Hologic, Inc.
6.3.1 Hologic, Inc. Company Information
6.3.2 Hologic, Inc. Description and Business Overview
6.3.3 Hologic, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hologic, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolio
6.3.5 Hologic, Inc. Recent Developments/Updates
6.4 Becton Dickinson & Company
6.4.1 Becton Dickinson & Company Company Information
6.4.2 Becton Dickinson & Company Description and Business Overview
6.4.3 Becton Dickinson & Company Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Becton Dickinson & Company Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolio
6.4.5 Becton Dickinson & Company Recent Developments/Updates
6.5 Cepheid, Inc.
6.5.1 Cepheid, Inc. Company Information
6.5.2 Cepheid, Inc. Description and Business Overview
6.5.3 Cepheid, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cepheid, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolio
6.5.5 Cepheid, Inc. Recent Developments/Updates
6.6 Danaher Corporation
6.6.1 Danaher Corporation Company Information
6.6.2 Danaher Corporation Description and Business Overview
6.6.3 Danaher Corporation Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Danaher Corporation Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolio
6.6.5 Danaher Corporation Recent Developments/Updates
6.7 Affymetrix, Inc.
6.7.1 Affymetrix, Inc. Company Information
6.7.2 Affymetrix, Inc. Description and Business Overview
6.7.3 Affymetrix, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Affymetrix, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolio
6.7.5 Affymetrix, Inc. Recent Developments/Updates
6.8 Alere, Inc.
6.8.1 Alere, Inc. Company Information
6.8.2 Alere, Inc. Description and Business Overview
6.8.3 Alere, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Alere, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolio
6.8.5 Alere, Inc. Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Company Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Abbott Laboratories Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 DiaSorin
6.10.1 DiaSorin Company Information
6.10.2 DiaSorin Description and Business Overview
6.10.3 DiaSorin Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 DiaSorin Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolio
6.10.5 DiaSorin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sexually Transmitted Diseases (STDs) Testing Devices Industry Chain Analysis
7.2 Sexually Transmitted Diseases (STDs) Testing Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sexually Transmitted Diseases (STDs) Testing Devices Production Mode & Process Analysis
7.4 Sexually Transmitted Diseases (STDs) Testing Devices Sales and 麻豆原创ing
7.4.1 Sexually Transmitted Diseases (STDs) Testing Devices Sales Channels
7.4.2 Sexually Transmitted Diseases (STDs) Testing Devices Distributors
7.5 Sexually Transmitted Diseases (STDs) Testing Devices Customer Analysis
8 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Dynamics
8.1 Sexually Transmitted Diseases (STDs) Testing Devices Industry Trends
8.2 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Drivers
8.3 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Challenges
8.4 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Roche Diagnostics
BioMerieux
Hologic, Inc.
Becton Dickinson & Company
Cepheid, Inc.
Danaher Corporation
Affymetrix, Inc.
Alere, Inc.
Abbott Laboratories
DiaSorin
听
听
*If Applicable.
